Several researchers have examined the IL-28B rs8099917 polymorphism in chronic viral hepatitis, however, this study represents an initial exploration ofthe impact of this SNP within the Egyptian HCV population receiving the SOF 400 mg/day and DAC 60 mg/day regimen [16, 51]. This evidence concerns the gene IFNL3 and animal viral hepatitis.